Organization: Health Canada
Year: 2022
Month: July
Request Number: A-2018-000999
Request Summary: All correspondence sent by Health Canada to Teva Pharmaceuticals USA between January 1, 1996 to January 1, 1998, with respect to the new drug submission for glatiramer acetate (tradename: COPAXONE, NDS 044430, rec. 1996-07-12), Notice of Compliance date 1997-09-04.
Disposition: Disclosed in part
Number of pages: 30